|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"im seock ah"
Showing items 1-8 of 8 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2022-04-15T02:33:29Z |
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study
|
Krop, Ian E; Im, Seock-Ah; Barrios, Carlos; Bonnefoi, Hervé; Gralow, Julie; Toi, Masakazu; Ellis, Paul A; Gianni, Luca; Swain, Sandra M; Im, Young-Hyuck; De Laurentiis, Michelino; Nowecki, Zbigniew; CHIUN-SHENG HUANG; Fehrenbacher, Louis; Ito, Yoshinori; Shah, Jigna; Boulet, Thomas; Liu, Haiying; Macharia, Harrison; Trask, Peter; Song, Chunyan; Winer, Eric P; Harbeck, Nadia |
| 臺大學術典藏 |
2022-04-14T23:27:49Z |
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis
|
Tan, Ryan Shea Ying Cong; Ong, Whee Sze; Lee, Kyung Hun; Lim, Abner Herbert; Park, Seri; Park, Yeon Hee; CHING-HUNG LIN; YEN-SHEN LU; Ono, Makiko; Ueno, Takayuki; Naito, Yoichi; Onishi, Tatsuya; Lim, Geok Hoon; Tan, Su Ming; Lee, Han Byoel; Ryu, Han Suk; Han, Wonshik; Tan, Veronique Kiak Mien; Wong, Fuh Yong; Im, Seock Ah; Tan, Puay Hoon; Chan, Jason Yongsheng; Yap, Yoon Sim |
| 臺大學術典藏 |
2022-03-22T15:05:34Z |
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
|
YEN-SHEN LU; Im, Seock Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Cardoso, Fatima; Harbeck, Nadia; Hurvitz, Sara; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; De Laurentiis, Michelino; Im, Young Hyuck; Kuemmel, Sherko; El-Saghir, Nagi; O'Regan, Ruth; Gasch, Claudia; Solovieff, Nadia; Wang, Craig; Wang, Yongyu; Chakravartty, Arunava; Ji, Yan; Tripathy, Debu |
| 臺大學術典藏 |
2021-11-21T23:19:52Z |
Genomic profiling of premenopausal HR+ and HER2– metastatic breast cancer by circulating tumor DNA and association of genetic alterations with therapeutic response to endocrine therapy and ribociclib
|
Bardia, Aditya; Su, Fei; Solovieff, Nadia; Im, Seock Ah; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Jung, Kyung Hae; Colleoni, Marco; Vázquez, Rafael Villanueva; Franke, Fabio; Hurvitz, Sara; Harbeck, Nadia; Chow, Louis; Taran, Tetiana; Lorenc, Karen Rodriguez; Babbar, Naveen; Tripathy, Debu; YEN-SHEN LU |
| 臺大學術典藏 |
2021-02-02T09:21:43Z |
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer
|
Schmid, Peter; Sablin, Marie Paule; Bergh, Jonas; Im, Seock Ah; Yen-Shen Lu; Martínez, Noelia; Neven, Patrick; Lee, Keun Seok; Morales, Serafín; Pérez-Fidalgo, J. Alejandro; Adamson, Douglas; Gonçalves, Anthony; Prat, Aleix; Jerusalem, Guy; Schlieker, Laura; Espadero, Rosa Maria; Bogenrieder, Thomas; Huang, Dennis Chin Lun; Crown, John; Cortés, Javier |
| 國立臺灣大學 |
2016 |
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial
|
Harbeck, Nadia; Huang, Chiun-Sheng; Hurvitz, Sara; Yeh, Dah-Cherng; Shao, Zhimin; Im, Seock-Ah; Jung, Kyung Hae; Shen, Kunwei; Ro, Jungsil; Jassem, Jacek; Zhang, Qingyuan; Im, Young-Hyuck; Wojtukiewicz, Marek; Sun, Qiang; Chen, Shin-Cheh; Goeldner, Rainer-Georg; Uttenreuther-Fischer, Martina; Xu, Binghe; Piccart-Gebhart, Martine; 黃俊升 |
| 國立臺灣大學 |
2015 |
Randomized Phase III trial of afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one prior trastuzumab treatment: LUX-Breast 1
|
Harbeck, Nadia; Huang, Chiun-Sheng; Hurvitz, Sara; Yeh, Dah-Cherng; Shao, Zhimin; Im, Seock-Ah; Jung, Kyung Hae; Shen, Kunwei; Ro, Jungsil; Jassem, Jacek; Zhang, Qingyuan; Im, Young-Hyuck; Wojtukiewicz, Marek; Sun, Qiang; Chen, Shin-Cheh; Goeldner, Rainer-Georg; Lahogue, Annick; Uttenreuther-Fischer, Martina; Xu, Binghe; Piccart-Gebhart, Martine; 黃俊升 |
| 國立臺灣大學 |
2012 |
LUX-breast 1: Randomized, phase III trial of afatinib and vinorelbine versus trastuzumab and vinorelbine in patients with HER2-overexpressing metastatic breast cancer (MBC) failing one prior trastuzumab treatment.
|
Harbeck, Nadia; Im, Seock-Ah; Huang, Chiun-Sheng; Im, Young-Hyuck; Xu, Binghe; Hurvitz, Sara A.; Lee, Keun-Seok; Ahn, Jin-Hee; Mehta, Ajay O.; Arora, Rajender Singh; Sun, Qiang; Qin, Shukui; Jacob, Linu Abraham; Jassem, Jacek; Staroslawka, Elzbieta; Sufliarsky, Jozef; Wojtukiewicz, Marek; Lahogue, Annick; Uttenreuther-Fischer, Martina Maria; Piccart-Gebhart, Martine J.; 黃俊升 |
Showing items 1-8 of 8 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
